Nanobiotix Ownership 2024 | Who Owns Nanobiotix Now?
Institutional Ownership
25.16%
Institutional Holders
11.00
Nanobiotix Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15.23% | 7.02% | 5,623,816 | - | - | 28,119,080 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 7.77% | 0.01% | 2,869,030 | - | - | 14,345,150 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.50% | 0.07% | 555,066 | - | - | 2,775,330 | Jun 30, 2024 |
| BLACKROCK INC. | 0.65% | - | 239,008 | -14,446 | -5.70% | 1,195,040 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,100 | - | - | 15,500 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 760 | 498 | 190.08% | 3,800 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 343 | -276 | -44.59% | 1,715 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 263 | 263 | 100.00% | 1,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.00% | - | 110 | 110 | 100.00% | 1,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 33 | - | - | 165 | Jun 30, 2024 |
| MORGAN STANLEY | - | - | 2 | - | - | 10 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
Nanobiotix's largest institutional shareholder is JOHNSON & JOHNSON, holding 15.23% of the company's total share outstanding, currently valued at $28.12M. The top 10 institutional shareholders own together 25.16% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15.23% | 7.02% | 5,623,816 | - | - | 28,119,080 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.50% | 0.07% | 555,066 | - | - | 2,775,330 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 7.77% | 0.01% | 2,869,030 | - | - | 14,345,150 | Jun 30, 2024 |
| BLACKROCK INC. | 0.65% | - | 239,008 | -14,446 | -5.70% | 1,195,040 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,100 | - | - | 15,500 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 343 | -276 | -44.59% | 1,715 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 760 | 498 | 190.08% | 3,800 | Jun 30, 2024 |
| BARCLAYS PLC | 0.00% | - | 110 | 110 | 100.00% | 1,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 263 | 263 | 100.00% | 1,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 33 | - | - | 165 | Jun 30, 2024 |
| MORGAN STANLEY | - | - | 2 | - | - | 10 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
The largest Nanobiotix shareholder by % of total assets is JOHNSON & JOHNSON. The company owns 5.62M shares of Nanobiotix (NBTX), representing 7.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 760 | 498 | 190.08% | 3,800 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 263 | 263 | 100.00% | 1,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.00% | - | 110 | 110 | 100.00% | 1,000 | Jun 30, 2024 |
| MORGAN STANLEY | - | - | 2 | - | - | 10 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 33 | - | - | 165 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,100 | - | - | 15,500 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 7.77% | 0.01% | 2,869,030 | - | - | 14,345,150 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.50% | 0.07% | 555,066 | - | - | 2,775,330 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 15.23% | 7.02% | 5,623,816 | - | - | 28,119,080 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 343 | -276 | -44.59% | 1,715 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 0.65% | - | 239,008 | -14,446 | -5.70% | 1,195,040 | Jun 30, 2024 |
As of Jun 30 2024, Nanobiotix's largest institutional buyer is BANK OF AMERICA CORP /DE/. The company purchased 498.00 stocks of NBTX, valued at $3.80K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 0.65% | - | 239,008 | -14,446 | -5.70% | 1,195,040 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 343 | -276 | -44.59% | 1,715 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 15.23% | 7.02% | 5,623,816 | - | - | 28,119,080 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.50% | 0.07% | 555,066 | - | - | 2,775,330 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 7.77% | 0.01% | 2,869,030 | - | - | 14,345,150 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,100 | - | - | 15,500 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 33 | - | - | 165 | Jun 30, 2024 |
| MORGAN STANLEY | - | - | 2 | - | - | 10 | Jun 30, 2024 |
| BARCLAYS PLC | 0.00% | - | 110 | 110 | 100.00% | 1,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 263 | 263 | 100.00% | 1,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 760 | 498 | 190.08% | 3,800 | Jun 30, 2024 |
As of Jun 30 2024, Nanobiotix's biggest institutional seller is BLACKROCK INC.. The company sold -14.45K shares of NBTX, valued at $1.20M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BARCLAYS PLC | 0.00% | - | 110 | 110 | 100.00% | 1,000 | Jun 30, 2024 |
Nanobiotix's largest new institutional shareholder by number of shares is BARCLAYS PLC, purchased 110.00 shares, valued at $1.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
Nanobiotix's largest sold out institutional shareholder by shares sold is TOWER RESEARCH CAPITAL LLC (TRC), sold -0.45K shares, valued at -, as of undefined.
Nanobiotix Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY CONCORD STREET TRUST | 0.00% | 5,809 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 253,454 | 34,740 | 15.88% | Mar 31, 2024 |
Nanobiotix's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 5.81K shares, compromising 0.00% of its total assets.
Nanobiotix Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | - |
| 31 Mar, 24 | 11 | -8.33% |
| 31 Dec, 23 | 12 | 33.33% |
| 30 Sep, 23 | 9 | 80.00% |
| 30 Jun, 23 | 5 | 25.00% |
| 31 Mar, 23 | 4 | -33.33% |
| 31 Dec, 22 | 6 | 20.00% |
| 30 Sep, 22 | 5 | -16.67% |
| 30 Jun, 22 | 6 | - |
| 31 Mar, 22 | 6 | -14.29% |
| 31 Dec, 21 | 7 | -22.22% |
| 30 Sep, 21 | 9 | -10.00% |
| 30 Jun, 21 | 10 | - |
| 31 Mar, 21 | 10 | -9.09% |
| 31 Dec, 20 | 11 | - |
As of 30 Jun 24, 11 institutions are holding Nanobiotix's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 9,291,531 | -0.17% |
| 31 Mar, 24 | 9,306,982 | 0.38% |
| 31 Dec, 23 | 9,271,461 | 107.49% |
| 30 Sep, 23 | 4,468,338 | 29.00% |
| 30 Jun, 23 | 3,463,804 | 0.03% |
| 31 Mar, 23 | 3,462,800 | -0.12% |
| 31 Dec, 22 | 3,466,905 | 0.11% |
| 30 Sep, 22 | 3,463,126 | -0.37% |
| 30 Jun, 22 | 3,476,133 | -0.15% |
| 31 Mar, 22 | 3,481,190 | -1.13% |
| 31 Dec, 21 | 3,520,885 | -14.00% |
| 30 Sep, 21 | 4,094,109 | -15.63% |
| 30 Jun, 21 | 4,852,401 | -0.30% |
| 31 Mar, 21 | 4,867,161 | -1.21% |
| 31 Dec, 20 | 4,926,653 | - |
Nanobiotix (NBTX) has 9.29M shares outstanding as of 30 Jun 24, down -0.17% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 25.16% | 3.57% |
| 31 Mar, 24 | 26.56% | 3.75% |
| 31 Dec, 23 | 26.60% | 16.18% |
| 30 Sep, 23 | 12.82% | 12.98% |
| 30 Jun, 23 | 9.94% | 10.07% |
| 31 Mar, 23 | 9.94% | 10.04% |
| 31 Dec, 22 | 9.95% | 10.07% |
| 30 Sep, 22 | 9.94% | 9.92% |
| 30 Jun, 22 | 10.01% | 9.96% |
| 31 Mar, 22 | 10.02% | 9.75% |
| 31 Dec, 21 | 10.14% | 7.30% |
| 30 Sep, 21 | 11.79% | 2.98% |
| 30 Jun, 21 | 19.90% | 5.00% |
| 31 Mar, 21 | 19.96% | 4.89% |
| 31 Dec, 20 | 20.20% | - |
As of 30 Jun 24, Nanobiotix is held by 25.16% institutional shareholders, representing a 3.57% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -40.00% |
| 31 Mar, 24 | 5 | -28.57% |
| 31 Dec, 23 | 7 | 16.67% |
| 30 Sep, 23 | 6 | 200.00% |
| 30 Jun, 23 | 2 | - |
| 31 Mar, 23 | - | -100.00% |
| 31 Dec, 22 | 2 | 100.00% |
| 30 Sep, 22 | 1 | - |
| 30 Jun, 22 | - | - |
| 31 Mar, 22 | - | - |
| 31 Dec, 21 | - | -100.00% |
| 30 Sep, 21 | 1 | - |
| 30 Jun, 21 | 1 | -50.00% |
| 31 Mar, 21 | 2 | -81.82% |
| 31 Dec, 20 | 11 | - |
3 institutional shareholders have increased their position in NBTX stock as of 30 Jun 24 compared to 5 in the previous quarter (a -40.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | 100.00% |
| 31 Mar, 24 | 1 | -66.67% |
| 31 Dec, 23 | 3 | 50.00% |
| 30 Sep, 23 | 2 | - |
| 30 Jun, 23 | - | -100.00% |
| 31 Mar, 23 | 1 | - |
| 31 Dec, 22 | - | - |
| 30 Sep, 22 | - | -100.00% |
| 30 Jun, 22 | 2 | - |
| 31 Mar, 22 | 2 | -33.33% |
| 31 Dec, 21 | 3 | 50.00% |
| 30 Sep, 21 | 2 | - |
| 30 Jun, 21 | 2 | -50.00% |
| 31 Mar, 21 | 4 | - |
| 31 Dec, 20 | - | - |
2 institutional shareholders have reduced their position in NBTX stock as of 30 Jun 24 compared to 1 in the previous quarter (a 100.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 11 | - | 9,291,531 | -0.17% | 25.16% | 3.57% | 3 | -40.00% | 2 | 100.00% |
| 31 Mar, 24 | 11 | -8.33% | 9,306,982 | 0.38% | 26.56% | 3.75% | 5 | -28.57% | 1 | -66.67% |
| 31 Dec, 23 | 12 | 33.33% | 9,271,461 | 107.49% | 26.60% | 16.18% | 7 | 16.67% | 3 | 50.00% |
| 30 Sep, 23 | 9 | 80.00% | 4,468,338 | 29.00% | 12.82% | 12.98% | 6 | 200.00% | 2 | - |
| 30 Jun, 23 | 5 | 25.00% | 3,463,804 | 0.03% | 9.94% | 10.07% | 2 | - | - | -100.00% |
| 31 Mar, 23 | 4 | -33.33% | 3,462,800 | -0.12% | 9.94% | 10.04% | - | -100.00% | 1 | - |
| 31 Dec, 22 | 6 | 20.00% | 3,466,905 | 0.11% | 9.95% | 10.07% | 2 | 100.00% | - | - |
| 30 Sep, 22 | 5 | -16.67% | 3,463,126 | -0.37% | 9.94% | 9.92% | 1 | - | - | -100.00% |
| 30 Jun, 22 | 6 | - | 3,476,133 | -0.15% | 10.01% | 9.96% | - | - | 2 | - |
| 31 Mar, 22 | 6 | -14.29% | 3,481,190 | -1.13% | 10.02% | 9.75% | - | - | 2 | -33.33% |
| 31 Dec, 21 | 7 | -22.22% | 3,520,885 | -14.00% | 10.14% | 7.30% | - | -100.00% | 3 | 50.00% |
| 30 Sep, 21 | 9 | -10.00% | 4,094,109 | -15.63% | 11.79% | 2.98% | 1 | - | 2 | - |
| 30 Jun, 21 | 10 | - | 4,852,401 | -0.30% | 19.90% | 5.00% | 1 | -50.00% | 2 | -50.00% |
| 31 Mar, 21 | 10 | -9.09% | 4,867,161 | -1.21% | 19.96% | 4.89% | 2 | -81.82% | 4 | - |
| 31 Dec, 20 | 11 | - | 4,926,653 | - | 20.20% | - | 11 | - | - | - |
Nanobiotix Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| CUE | Cue Biopharma, Inc. |
| CNSP | CNS Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| TCRX | TScan Therapeutics, Inc. |
| AVRO | AVROBIO, Inc. |
| DRMA | Dermata Therapeutics, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| ANNX | Annexon, Inc. |
| WVE | Wave Life Sciences Ltd. |
| IMMX | Immix Biopharma, Inc. |
| CYTO | Altamira Therapeutics Ltd. |
| INAB | IN8bio, Inc. |
| TFFP | TFF Pharmaceuticals, Inc. |
| CGTX | Cognition Therapeutics, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ZURA | Zura Bio Limited |
| ENVB | Enveric Biosciences, Inc. |
| PALI | Palisade Bio, Inc. |
NBTX Ownership FAQ
Who Owns Nanobiotix?
Nanobiotix is owned by institutional shareholders (25.16%), insiders (0.00%), and public (74.84%). The largest institutional shareholder of Nanobiotix is JOHNSON & JOHNSON (15.23% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Nanobiotix?
Nanobiotix's major institutional shareholders are JOHNSON & JOHNSON, BAILLIE GIFFORD & CO, PERCEPTIVE ADVISORS LLC, BLACKROCK INC., and UBS GROUP AG. The top five shareholders own together 25.16% of the company's share outstanding.
How many Nanobiotix shareholders are there?
As of Jun 2024, there are 11 institutional shareholders of Nanobiotix.
What percentage of Nanobiotix is owned by JOHNSON & JOHNSON?
JOHNSON & JOHNSON owns 5.62M shares of Nanobiotix, representing 15.23% of the company's total shares outstanding, valued at $28.12M (as of Jun 2024).
What percentage of Nanobiotix is owned by BAILLIE GIFFORD & CO?
As of Jun 2024, BAILLIE GIFFORD & CO holds 2.87M shares of Nanobiotix (NBTX), compromising 7.77% of the company, valued at $14.35M.
What percentage of Nanobiotix is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC is the third largest holder of Nanobiotix. The company owns 555.07K of the company's shares outstanding (worth $2.78M).